Bank of America's NII is climbing on asset repricing and loan growth, but looming Fed rate cuts may slow the pace.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

CoreWeave (NASDAQ:CRWV) shares tumbled in early trading as the AI cloud-computing startup posted a wider-than-expected loss for the second quarter. It reported a net loss of $290.5 million, above Street estimates of a loss of $190 million.

AST SpaceMobile, Inc. offers a high-risk, high-reward opportunity, hinging on their ambitious plan to deliver direct satellite-to-phone connectivity worldwide. The investment case is driven by execution milestones—successful launches, service rollouts, and converting partnerships into real revenue, not current fundamentals. Cash burn is significant; any delay, technical failure, or regulatory setback could lead to rapid share price declines or heavy dilution.

Evaluate the expected performance of Palo Alto (PANW) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

The current market environment, characterized by easing inflation fears and a potential shift in Federal Reserve policy toward lower interest rates, is a favorable backdrop for small cap stocks.

Visteon (VC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Valmont (VMI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Vontier (VNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Lucid Diagnostics Inc. (LUCD) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.2 per share a year ago.

Dorman Products (DORM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Primoris Services (PRIM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Xometry (XMTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

MIAMI, Aug. 13, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered through its Next Utility Operating System®, smart microgrids, wireless (in-motion) EV charging, and mobile fuel delivery, today announced the appointment of Michael Weisz to its Strategic Advisory Board. Weisz is the Founder and former CEO of Yieldstreet, the largest direct-to-consumer alternative investment platform in the U.S., where he founded and scaled the company into a global online investment powerhouse enabling affluent retail investors to diversify their portfolios beyond the stock market.

YONKERS, N.Y., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest townhome community, Enclave at Sprain Brook, is now open for sale in Yonkers, New York. Situated just 17 miles from Manhattan, this intimate community of only 28 homes offers a suburban lifestyle with easy access to New York City.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

VerifyMe, Inc. (VRME) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.03 per share a year ago.